Pacifica Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36K | Hold |
50
| – | – | ﹤0.01% | 491 |
|
|
2025
Q1 | $1.29K | Sell |
50
-100
| -67% | -$2.57K | ﹤0.01% | 474 |
|
|
2024
Q4 | $6.3K | Sell |
150
-30
| -17% | -$1.26K | ﹤0.01% | 360 |
|
|
2024
Q3 | $12K | Hold |
180
| – | – | 0.01% | 341 |
|
|
2024
Q2 | $20.9K | Buy |
180
+30
| +20% | +$3.48K | 0.01% | 295 |
|
|
2024
Q1 | $16.5K | Sell |
150
-50
| -25% | -$5.52K | 0.01% | 313 |
|
|
2023
Q4 | $15.7K | Hold |
200
| – | – | 0.01% | 325 |
|
|
2023
Q3 | $20.6K | Buy |
200
+150
| +300% | +$15.4K | 0.01% | 282 |
|
|
2023
Q2 | $6.18K | Sell |
50
-15
| -23% | -$1.85K | ﹤0.01% | 349 |
|
|
2023
Q1 | $10.2K | Buy |
65
+15
| +30% | +$2.36K | 0.01% | 305 |
|
|
2022
Q4 | $9.02K | Hold |
50
| – | – | 0.01% | 293 |
|
|
2022
Q3 | $7K | Buy |
50
+20
| +67% | +$2.8K | 0.01% | 334 |
|
|
2022
Q2 | $4K | Buy |
+30
| New | +$4K | ﹤0.01% | 392 |
|